Literature DB >> 17349813

Non-motor dysfunction in Parkinson's disease.

Tjalf Ziemssen1, Heinz Reichmann.   

Abstract

In the field of neurology, Parkinson's disease (PD) is commonly perceived to be a disorder affecting only the (extrapyramidal) motor system, characteristically manifesting as bradykinesia, rigidity, tremor and postural instability. Although non-motor symptoms such as behavioural abnormalities, dysautonomia, sleep disturbances and sensory dysfunctions are also common and quite disabling manifestations of the disease, they are often not formally assessed and thus are frequently misdiagnosed and/or under diagnosed. For this reason, in this review we have concentrated on the pathophysiological and clinical basis of non-motor involvement such as olfactory dysfunction, depression, dementia, dysautonomia and sleep disorders in PD. The early recognition of these symptoms may well perhaps lead to an earlier diagnosis of PD, but in any case should lead to more prompt and effective treatment of the relatively unrecognized non-motor problems associated with PD.

Entities:  

Mesh:

Year:  2007        PMID: 17349813     DOI: 10.1016/j.parkreldis.2006.12.014

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  58 in total

Review 1.  Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment.

Authors:  Karen L Eskow Jaunarajs; Mariana Angoa-Perez; Donald M Kuhn; Christopher Bishop
Journal:  Neurosci Biobehav Rev       Date:  2010-07-06       Impact factor: 8.989

2.  Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit.

Authors:  N Rampersaud; A Harkavyi; G Giordano; R Lever; J Whitton; Ps Whitton
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

3.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

4.  Treatment of dysautonomia in extrapyramidal disorders.

Authors:  Tjalf Ziemssen; Heinz Reichmann
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

Review 5.  Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease.

Authors:  Derek A Drechsel; Manisha Patel
Journal:  Free Radic Biol Med       Date:  2008-03-04       Impact factor: 7.376

6.  Valsalva manoeuvre in patients with different Parkinsonian disorders.

Authors:  C Schmidt; B Herting; S Prieur; S Junghanns; K Schweitzer; C Globas; L Schöls; H Reichmann; D Berg; Tjalf Ziemssen
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

7.  Baroreflex sensitivity and power spectral analysis in different extrapyramidal syndromes.

Authors:  C Friedrich; H Rüdiger; C Schmidt; B Herting; S Prieur; S Junghanns; K Schweitzer; C Globas; L Schöls; D Berg; H Reichmann; T Ziemssen
Journal:  J Neural Transm (Vienna)       Date:  2008-09-20       Impact factor: 3.575

8.  Dream features in the early stages of Parkinson's disease.

Authors:  Paulo Bugalho; Teresa Paiva
Journal:  J Neural Transm (Vienna)       Date:  2011-06-30       Impact factor: 3.575

9.  Decreased response of interneurons in the medial prefrontal cortex to 5-HT₁A receptor activation in the rat 6-hydroxydopamine Parkinson model.

Authors:  Qiaojun Zhang; Shuang Wang; Lina Zhang; Huan Zhang; Hongfei Qiao; Xiaolin Niu; Jian Liu
Journal:  Neurol Sci       Date:  2014-02-22       Impact factor: 3.307

10.  Mismatch negativity-like potential (MMN-like) in the subthalamic nuclei in Parkinson's disease patients.

Authors:  Eduard Minks; Pavel Jurák; Jan Chládek; Jan Chrastina; Josef Halámek; Daniel J Shaw; Martin Bareš
Journal:  J Neural Transm (Vienna)       Date:  2014-05-09       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.